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Abstract: Lung cancer is the leading cause of cancer death and morbidity worldwide. Many studies 
have shown machine learning models to be effective in detecting lung nodules from chest X-ray 
images. However, these techniques have yet to be embraced by the medical community due to 
several practical, ethical, and regulatory constraints stemming from the “black-box” nature of deep 
learning models. Additionally, most lung nodules visible on chest X-rays are benign; therefore, the 
narrow task of computer vision-based lung nodule detection cannot be equated to automated lung 
cancer detection. Addressing both concerns, this study introduces a novel hybrid deep learning and 
decision tree-based computer vision model, which presents lung cancer malignancy predictions as 
interpretable decision trees. The deep learning component of this process is trained using a large 
publicly available dataset on pathological biomarkers associated with lung cancer. These models 
are then used to inference biomarker scores for chest X-ray images from two independent data sets, 
for which malignancy metadata is available. Next, multi-variate predictive models were mined by 
fitting shallow decision trees to the malignancy stratified datasets and interrogating a range of 
metrics to determine the best model. The best decision tree model achieved sensitivity and 
specificity of 86.7% and 80.0%, respectively, with a positive predictive value of 92.9%. Decision trees 
mined using this method may be considered as a starting point for refinement into clinically useful 
multi-variate lung cancer malignancy models for implementation as a workflow augmentation tool 
to improve the efficiency of human radiologists. 
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Lung cancer is the leading cause of cancer-related deaths worldwide [1], with over 
two million new cases documented in 2018 and a projected 2.89 million cases by 2030 [2]. 
There is a long history of research into the automated diagnosis of lung cancer from 
medical images using computer vision techniques encompassing linear and non-linear 
filtering [3], grey-level thresholding analysis [4], and, more recently, machine learning 
including deep learning techniques [5–7]. Despite many lab-based successes of computer 
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vision medical image diagnostic algorithms, the actual regulatory approval and clinical 
adoption of these computer vision techniques in medical image analysis is very limited 
[8]. Clinical use of medical image AI is held back by the dissonance of evidence-based 
radiology [9] with the black-box nature of deep learning systems, along with data quality 
concerns and legal/ethical issues such as responsibility for errors [10]. As of September 
2020, the U.S. Food and Drug Administration (FDA) has approved only 30 radiology 
related deep learning or machine learning based applications/devices, of which only three 
utilize the X-ray imaging mode [11], with the subject of one being wrist fracture diagnosis 
[12] and the other two being for pneumothorax assessment [13,14]. 
In contrast to the limited number of field applications relating to clinical use of 
machine learning in radiology, there exists a massive corpus of published research in this 
field [15,16]. The Scopus database [17] returns over 700 results for a title and abstract 
search on (“Computer Vision” OR “Machine Learning” OR “Deep Learning” AND chest 
AND X-ray). The overwhelming majority of these papers have been authored in the past 
decade, as shown in Figure 1. 
 
Figure 1. Scopus bibliographic histogram relating to machine learning/deep learning and chest X-
ray showing exponential growth in published works over the past decade. 
Driving this huge interest in medical computer vision research is a desire to provide 
tools to improve the productivity of medical clinicians by providing an automated second 
reading to assist radiologists with their workloads [8]. This ambitious goal has technically 
been met by development studies under lab conditions [18], but persistent challenges 
including dataset size and diversity, along with bias detection/removal and expertise in 
oversight and safe use of such systems remain hinderances to clinical adoption [19]. 
1.2.  Study Goals and Process Overview 
The primary goal of this paper is to present a novel framework that automatically 
generates interpretable models for the stratification of lung cancer chest X-ray (CXR) 
images into benign and malignant samples. Rather than aiming to provide a narrow, 
automated CXR second reading using a feature extraction model for lung nodules as 
exhaustively discussed in [20], our objective is to autonomously create a range of 
reasonable and explainable decision tree models for lung cancer malignancy stratification 
using multiple pathological biomarkers for lung cancer as features. Our intention is that 
that these models can be used by the medical community as a data driven foundation for 
interpretable multivariate diagnostic scoring of lung cancer and form the basis of useful 
workflow augmentation tools for radiologists. 
We extend the well-researched method of training a deep learning algorithm, 
typically a variant of the Convolutional Neural Network (CNN) architecture [21], in lung 
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nodule detection and classification into a two-step approach that combines deep learning 
feature extraction with the fitting of shallow decision trees. 
Firstly, we investigate lung pathology features that are considered biomarkers 
closely associated with lung cancer. We then use CXR examples of these pathologies to 
train a multi-class deep learning algorithm. Secondly, the score for each pathological 
feature is inferenced from the trained model for two independent lung cancer CXR 
datasets for which malignancy scoring metadata is available. Finally, this inferenced score 
tuple is fitted to the malignancy data for each patient using a shallow decision tree, with 
the most accurate decision trees extracted for discussion and further refinement. This 
process is illustrated in Figure 2. 
 
Figure 2. Automated lung cancer malignancy decision tree mining process showing deep learning 
flow for feature scoring, and decision tree flow for multi-variate model generation. 
This more holistic approach emphasizes the importance of multiple pathological 
biomarkers as lung cancer features, avoiding automation bias by the promotion of 
interpretability and expert human judgement in the creation of medical computer vision 
applications. It is hoped that this change of focus may help overcome the hurdles that 
have held back the adoption medical artificial intelligence algorithms into clinical 
workflow by enabling radiologists to oversee the advice provided by computer vision 
models, thereby promoting evidence-based and safe use of the technology [19]. 
1.3. Novelty and Major Contributions 
Our key contributions stem from our novel combination of simple, proven 
techniques into an end-to-end process that mines interpretable models for the diagnosis 
and stratification of lung cancer. This process provides the medical community with two 
key novel elements. Firstly, we show that automated lung nodule detection from CXR 
alone is insufficient to indicate lung cancer malignancy. We therefore train our deep 
learning classifier on additional pathologies associated with lung cancer outside of the 
well-studied and narrow lung nodule classification task. This more closely matches the 
partially subjective workflow process of human radiologists [8] than other published 
studies. Secondly, our process provides an interpretable and logical explanation of model 
output for lung cancer malignancy stratification rather than the simple ‘black box’ score 
and visual, but not necessarily interpretable, saliency mapping that is common to other 
studies. 
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2. Related Work 
2.1. Automated Lung Cancer Diagnosis 
Although the Computed Tomography (CT) imaging mode has attracted most of 
research into machine learning based automated lung disease diagnosis, there are several 
studies that show the usefulness of CXR for this task. Best results against the very large 
ChestX-ray14 dataset [22] have been achieved using deep learning combined with 
trainable attention mechanisms for channels, pathological elements, and scale [23], 
achieving an average AUC of 0.826 for 14 thoracic conditions. Other recently published 
approaches include incorporation of label inter-dependencies via LSTM modules to 
improve prediction accuracy using statistical label correlations [24], augmenting deep 
learning with hand crafted shallow feature extraction [25] to improve classification 
accuracy over pure deep learning, and consideration of the relationship between 
pathology and location in the lung geometry as spatial knowledge to improve deep 
learning classification accuracy [26]. Each of these approaches improved upon the 
accuracy obtained from a pure deep learning approach by finding and exploiting 
additional information from the ChestX-ray14 dataset, however, none of these studies 
considered whether the additional information gleaned is generalizable. For instance, 
some label interdependencies may be specific to the clinic and radiologist population from 
which the ChestX-ray14 dataset was sourced and labelled. Likewise, the shallow feature 
extraction approach from [25] evaluated and tuned feature extraction algorithms to 
produce the best results against the ChestX-ray14 dataset, without experimenting to 
assess whether and to what extent this approach was generalizable to an independent 
dataset. 
Very good results in lung nodule detection using deep learning have been achieved 
by teams using nodule-only datasets, with a systematic survey for this research being 
provided by [27]. State of the art lung nodule detection from CXR was achieved by X. Li 
et al. [6] using a hand-crafted CNN consisting of three dense blocks, each with three 
convolution layers. In this study, images from the Society of Radiological Technology 
(JSRT) dataset [28] were divided into patches of three different resolutions resulting in 
three trained CNNs, which were then fused. This scheme detected over 99% of lung 
nodules from the JSRT dataset with 0.2 false positives per image and achieved an AUC of 
0.982. Despite these excellent results, this study did not stratify the detected nodules into 
malignant or benign categories, nor did this study perform generalization tests to confirm 
that the proposed model performed well against independent datasets. 
Stratification of the JSRT dataset into malignant and benign nodule cases was 
achieved by [5] using a chained training approach. In this paper, a pretrained DenseNet-
121 CNN was firstly trained on the ChestX-ray14 dataset [22] followed by retraining on 
the JSRT dataset. This model achieved accuracy, specificity, and sensitivity metrics for 
nodule malignancy of 0.744, 0.750 and 0.747, respectively. Once again, there were no 
generalization tests performed in this study. 
Lung nodule classification studies typically utilize the Japanese Society of 
Radiological Technology (JSRT) dataset [28] as a machine learning training corpus. This 
dataset includes 150 samples with a nodule size of 3 cm or less, but only four samples with 
a nodule size greater than 3 cm. Use of the JSRT datasets in this manner is potentially 
problematic for two reasons; firstly, a lung nodule is defined as measuring ≤ 3 cm in 
diameter [29] with larger nodules or masses under-represented in these studies, even 
though these may indicate more serious and likely malignant cancers, and secondly, most 
pulmonary nodules are benign [30]. The CXR imaging mode is much more sensitive to 
calcified benign nodules (due to associated higher opacity) than non-calcified nodules or 
ground-glass opacities [31], which are more likely to be a sign of lung cancer [32]. These 
factors combined could lead to deep learning systems trained only on CXR nodule 
detection tending to under-diagnose serious nodules and/or masses over 3 cm in 
diameter, which is obviously undesirable. It is these concerns that have led us to 
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investigate biomarker features other than visible nodules alone in the detection and 
malignancy stratification of lung cancer malignancy from CXR. 
2.2. Automated Diagnostic Scoring 
Interest in pathology severity scoring from CXR images has received much recent 
focus due to the COVID-19 pandemic commencing in 2020. A combination of deep 
learning feature extraction and logistic regression fit to severity has shown to be predictive 
of the likelihood of ICU admission for COVID-19 patients [33]. Many papers relating to 
classification and stratification of lung nodules detected from the CT imaging mode have 
been published employing various deep learning techniques [34,35], however few such 
papers have been published for the CXR imaging mode. This is due to the CXR imaging 
mode having lower sensitivity in comparison to the CT imaging mode [36], making 
nodule characterization and stratification difficult using segmentation and shape analysis 
techniques developed for higher resolution CT images. 
The most comprehensive study into the use of CXR for pathological scoring was 
performed by [37], where deep learning was used to score long-term mortality risk from 
prostate, lung, colorectal and ovarian cancer across two randomized clinical trials. 
Patients were stratified into five risk categories (very low, low, moderate, high, and very 
high) based on a pre-trained inception [38]. CNN-based scoring of the patient’s initial CXR 
[37] concluded that the deep learning classifier was capable of accurate stratification of 
the risk of long-term mortality from an initial CXR. The study noted that most of these 
deaths were from causes other than lung cancer and speculated that the developed CNN 
and risk stratification reflected shared risk factors [39] apparent as biomarkers on CXR. 
This study shares our use of a CNN to score a range of pathologies for downstream 
generation of risk models, although it should be noted that our study aims to stratify lung 
cancer malignancy rather than long-term mortality. 
3. Materials and Methods 
3.1. Data Sourcing 
To achieve our objective of automatically generating explainable lung cancer 
malignancy models, two logical datasets are needed. The first is a large corpus of labelled 
CXR data that can be used to train a deep learning classifier as a multi-pathology feature 
extraction component. The National Institute of Health ChestX-ray14 dataset [22] 
provides 112,120 frontal-view X-ray images of 30,805 unique patients. ChestX-ray14 
images are uniformly 1024 × 1024 pixels in a portrait orientation with both Posterior-
Anterior (PA) and Anterior-Posterior (AP) views. The second logical dataset must 
comprise CXRs with malignancy metadata, indicating whether lung cancer is present in 
the image and, if so, whether the cancer is considered by expert radiologists to be benign 
or malignant. There are two publicly available CXR datasets meeting these criteria. Firstly, 
the Lung Image Database Consortium Image Collection (LIDC-IDRI) [40] provides 
malignancy diagnosis metadata for 157 patient studies, of which 96 include PA view CXR 
images. Secondly, the Japanese Society of Radiological Technology (JSRT) [28] database 
provides 154 patient studies in the form of PA CXR images with malignancy diagnosis 
metadata. The JSRT dataset was labelled for lung nodule malignancy and subtlety by a 
panel of 20 experienced radiologists. The JSRT dataset is provided in Universal image 
format (no header, big-endian raw data), which was converted to Portable Network 
Graphics (PNG) format using the OpenCV [41] python library. The LIDC-IDRI dataset is 
provided in “Digital Imaging in Medicine” (DICOM) format and these files were 
converted to PNG format with the Pydicom [42] library using a grayscale colormap. 
The LIDC-IDRI dataset has been manually labelled by four radiologists with access 
to corresponding patient CT scans. The label metadata has been provided at the patient 
level, meaning that there are some images provided where the nodule location is known 
and logged from the CT scan but not visible on the CXR image. Normally, any such 
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inconsistency between the dataset and labels would be problematic for a computer vision 
diagnosis, since the image data would not support the label ground truth. Similarly, the 
JSRT dataset contains some nodules that are very subtle. For these subtle nodules of size 
1–10 mm, human expert radiologist sensitivity was measured at only 60.4% [28]. Our 
proposed classification process should be relatively robust against these problems, since the 
presence of obvious nodules is only one of several lung cancer biomarkers under 
consideration. 
3.2. Data Curation 
The ChestX-ray14 data set was labelled using natural language processing to extract 
disease classes for each image from the associated radiology report, which the dataset 
authors report is of greater than 90% accuracy. Many of the images have a mix of disease 
classes. Since our objective is to achieve explainable lung cancer scores, we have restricted 
this study to images labelled with only a single disease class. 
Of the 13 disease classes included in the ChestX-ray14 data set, not all are associated 
with lung cancer. To either exclude or include the classes, the simple rule was applied. If 
the literature noted a general indicative connection between lung cancer and the class in 
question, then that class was extracted from the ChestX-ray14 set for further analysis. The 
only exception to this inclusion rule is the “No Finding” class, which was included to 
enrich the generated models with a pathology contra-indicator. This resulted in five 
classes of interest for this study being Atelectasis, Effusion, Mass, No Finding, and 
Nodule. Once filtered in this way, the totals for images in this dataset are as shown in 
Table 1. 
To address class imbalance during training, each class was under-sampled to 2000 
examples of each class. The remaining class imbalance caused by the “Mass” and 
“Nodule” labels as minority classes (with 1367 and 1924 samples, respectively) was 
addressed in training by employing a weighted random sampler in the data loader. 
Standard augmentations were applied only to the training ChestX-ray14 dataset with 
random rotation of 1 degree of expansion, and random horizontal flip. Vertical flipping 
was not used since CXR images were not vertically symmetrical. The images were resized 
with a default classifier size of 299 × 299 pixels for ResNet-50 [43] and ResNext-50 [44] and 
244 × 244 pixels for other classifiers including DenseNet-121 [45], VGG-19 [46] and 
AlexNet [47]. Training and testing were run with and without equalization. 
The ChestX-ray14 dataset was split into an 80:20 training and validation pair, 
resulting in 6641 images for training and 1661 images for validation. A set of 6085 images 
conforming to the official test split for ChestX-ray14 was used as a holdout test set. These 
images were drawn from the official test split to ensure that there was no patient overlap 
between the data used for training/validation and testing. 
Table 1. Summary of ChestX-ray14 images extracted for deep learning. 
Classification Count Extracted Association 
Atelectasis 2210 Y Documented as a first sign of lung cancer [48]. 
Cardiomegaly 746 N 
Not related to lung cancer although in rare cases 
misdiagnosed when underlying condition is mass 
in same geography of CXR [49]. 
Consolidation 346 N 
Can sometimes accompany lung cancer but 
usually associated with pneumonia [50]. 
Edema 51 N Can be a complication from treatment for lung 
cancer but does not indicate lung cancer [51]. 
Effusion 2086 Y Can be caused by a build-up of cancer cells and a 
common complication of lung cancer [52]. 
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Emphysema 525 N Linked as a risk factor for lung cancer but not an 
indication [53]. 
Fibrosis 648 N Linked as a risk factor for lung cancer but not an indication [54]. 
Hernia 98 N 
Mistaken for lung cancer but does not indicate 
lung cancer [55]. 
Infiltration 5270 N 
Generic descriptor used informally in radiological 
reports and not actually an accepted lung disease 
classification. 
Mass 1367 Y A primary indication of lung cancer [51]. 
No Finding 39,302 Y 
Not lung (by definition) cancer but included to 
enrich generated models with a counter-indicator. 
Nodule 1924 Y 
A primary indication of lung cancer [51,56] with 




This is often an indication of mesothelioma caused 
by exposure to asbestos. It is also a very common 
abnormal finding on CXR. It is not an indication of 
lung cancer [57]. 
Pneumonia 176 N 
Often a complication of lung cancer [50] with 50-
70% of patients developing a lung infection. 
Persistent pneumonia can lead to a diagnosis of 
lung cancer. Not typically used as indicator of 
lung cancer. 
Pneumothorax 1506 N Can be the first sign of lung cancer but this is rare [58]. 
3.3. Model Development 
3.3.1. Network Selection 
Following experimentation with a number of classifiers, including VGG-19 [46], 
AlexNet [47], DenseNet-121 [45], ResNet-50 [43] and ResNext-50 [44], we found that the 
DenseNet-121 and ResNet-50 networks initialized with ImageNet [59] weights 
consistently provided the equivalent and best results. We therefore selected the 
DenseNet121, and ResNet-50 network architectures for this study, which is consistent 
with other studies relating to the use of deep learning classifiers on large CXR datasets 
[23,60–62], with DenseNet being the most popular neural network architecture for lung 
CXR studies [63], and ResNet allowing for larger input images which would theoretically 
improve nodule localization. Noting that several state-of-the-art studies have employed 
network attention mechanisms in computer vision applications we additionally tested 
with a variant of ResNet-50 using a triple attention mechanism, which applies attention 
weights to channels and spatial dimensions using three separate branches covering 
channel/width, channel/height and width/height as described in detail by [64]. 
We followed standard practice employed in transfer learning [65] and replaced the 
network head fully connected layer (by default 1000 neurons) with the number of 
classification outputs required by the experiment being five. These five output nodes 
matched our five selected features being Atelectasis, Effusion, Mass, No Finding, and 
Nodule. This network was then fine-tuned using the training data subset of ChestX-ray14, 
achieving AUC-ROC results consistent with state-of-the-art for this dataset in 
consideration that we have restricted classes to PA view only and under-sampled (Table 
2). All models converged well as shown in Figure 3, with the ResNet based networks being 
fully trained at 25 epochs compared to Densenet-121, requiring around 50 epochs to fully 
train. 
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Table 2. Comparison of achieved AUC-ROC scores for ChestX-ray14 holdout test subset to other 
published works using similar techniques. 
Configuration Atelectasis Effusion Mass Nodule 
Test A (Epoch 17) 0.782 0.858 0.811 0.705 
Test B (Epoch 7) 0.780 0.833 0.808 0.760 
Test C (Epoch 8) 0.770 0.863 0.808 0.739 
Wang et al. (2017) [22] 0.700 0.759 0.693 0.669 
Wang et al. (2021) [23] 0.779 0.836 0.834 0.777 
Yao et al. [24] 0.772 0.859 0.792 0.717 
 
 
(a) DenseNet-121 training curve showing training complete at 50 epochs. 
 
(b) ResNet-50 training curve showing training complete at 25 epochs 




(c) ResNet-50 with Triplet Attention training curve showing training complete at 25 epochs 
Figure 3. Training and validation loss/accuracy curves for DenseNet-121 (a), ResNet-50 (b), and 
ResNet-50 with Triplet Attention (c). 
Experimentation showed that the Adam optimizer [66] led to faster convergence and 
more accurate results (by around 5%) over the SGD [67] optimizer, therefore we chose to 
use the Adam optimizer with standard parameters (β1 = 0.9 and β2 = 0.999), along with a 
cosine annealing learning rate scheduler with an initial learning rate of 0.001 for Densenet-
121 and 0.0004 for the Resnet-based classifiers. These rates were tuned by experimentation 
to produce the highest holdout test accuracy. The cosine annealing scheduler was selected 
because during model testing and hyperparameter optimization, it was noticed that the 
model trained well with a more aggressive learning rate, leading to higher validation 
accuracy at a lower number of epochs. 
Upon inspection of the dataset images, we noticed a high degree of variation of 
brightness and contrast, both within and across the ChestX-ray14 and LIDC-IDRI datasets, 
as shown is Figure 4a,b. The JSRT dataset has consistent brightness and contrast since it 
was automatically equalized at extraction from raw image format, as evident from Figure 4c. 
 
(a) Montage of ChestX-ray14 images 




(b) Montage of LIDC-IDRI images 
 
(c) Montage of JSRT images 
Figure 4. CXR montages for (a) ChestX-ray14, (b) LIDC-IDRI and (c) JSRT datasets showing inter 
and intra dataset brightness and contrast variation. 
There was some concern regarding these differences in image brightness and 
contrast, which would confound deep learning model training. To minimize the inter and 
intra dataset differences in brightness and contrast, the models were trained and tested 
with standard histogram equalization as part of the image pre-processing pipeline. The 
experiments performed are summarized in Table 3. 
Table 3. Summary of Training/Test Scenarios. 
Test Network Architecture 
A Densenet-121 pretrained with ImageNet weights 
B Resnet-50 pretrained with ImageNet weights 
C Resnet-50 with Triplet Attention/pretrained with ImageNet weights 
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3.3.2. Deep Learning Model Performance 
The results of 10 training/holdout testing runs are shown in Figures 5–7. The holdout 
test split used was a subset of the recommended ChestX-ray14 test split containing the 
extracted classes, as listed in Table 1. 
 
Figure 5. Average AUC-ROC for 10 rounds of holdout testing (Test A). 
 
Figure 6. Average AUC-ROC for 10 rounds of holdout testing (Test B). 
 
Figure 7. Average AUC-ROC for 10 rounds of holdout testing (Test C). 
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Excellent holdout testing results were achieved from all experiments. Test A achieved 
a maximum average AUC value of 0.789 at epoch 17. Tests B achieved a maximum average 
AUC value of 0.793 at epoch 5. Test C achieved a maximum average AUC value of 0.795 
at epoch 10. Each of these results could be considered outliers from individual runs, and 
the average lines plotted in Figures 5–7 give a better indication of real-world performance 
accounting for error margins, being 0.770, 0.771, and 0.777 for tests A, B and C respectively. 
The overall best results were achieved by experiment C, with 4 models achieving 
average AUC above 0.790, and a superior mean profile in the range 10–20 epochs, which 
is interpreted as a reduced tendency to overfit, thereby promoting our objective of 
generating good decision tree fitted models in the downstream process. In contrast, 
experiment B resulted in only one model with average AUC above 0.790 and experiment 
A resulted in no single models with average AUC above 0.790. 
Best AUC-ROC values for the extracted features for each tested configuration are 
shown in Table 2. The AUC-ROC values for the same conditions from the original ChestX-
ray14 paper are also included as a baseline [22], along with the most relevant state-of-the-
art results from [23], using a triple attention network with a DenseNet-121 backbone, and 
[24], which also considered additional pathologies in their multi-classifier, used mixed 
label images, and did not restrict the CXR images to PA projections. These studies also 
did not include the “No Finding” class in training or inferencing. Due to these differences 
in methods, our results are not directly comparable to these studies; the results have been 
compared only to establish that our deep learning models have comparable or better 
performance than similar, but not identical development models, and are a good basis for 
the following step of our process, being the fitting of shallow decision trees to these 
models. 
3.3.3. Deep Learning Model attention via Saliency Mapping 
The ChestX-ray14 dataset provides bounding box co-ordinate metadata for the 
pathologies present in a small subset of CXR images. These bounding boxes have been 
hand-labelled by a board-certified radiologist [22] and are useful for disease localization 
ground-truth comparison to classifier predictions. We used a Grad-CAM [68] 
visualization to compare our models’ predictions to ground truth from the ChestX-ray14 
dataset bounding metadata with a selection of results shown in Figure 8a–p. 
Atelectasis 
    
 (a) ground truth (b) experiment A (c) experiment B (d) experiment C 
Effusion 
    
 (e) ground truth (f) experiment A (g) experiment B (h) experiment C 




    
 (i) ground truth (j) experiment A (k) experiment B (l) experiment C 
Nodule 
    
 (m) ground truth (n) experiment A (o) experiment B (p) experiment C 
Figure 8. Ground truth comparison localization vs. Grad-CAM visualized predicted location for tested network architectures. 
These results were generated from the model with the highest validation score from 
each experiment training round. Overall, the results showed a good correlation between 
the model’s predicted localization and the provided ground-truth. We noted that 
experiments B and C tended to produce the best localization results, with experiment C 
(being the ResNet-50 triplet attention network) providing the best localization 
performance overall, with particularly good results for the difficult “nodule” class, which 
was relatively poorly localized in experiments A and B using networks without attention 
mechanisms. 
3.4. Malignancy Model Generation 
Of the 157 patient studies from the LIDC-IDRI annotated with patient level diagnosis, 
120 DICOM files contained both CT and CXR images, with the remaining 37 containing 
only CT scans. The 120 CXR images were extracted into a PNG format as earlier described 
to match the classifier input data format. Twenty-four of these images were labelled with 
a diagnosis of “Unknown” and were excluded from further analysis. The remaining 96 
records were categorized by the LIDC-IDRI as follows in Table 4. 
Table 4. LIDC-IDRI patient level diagnosis metadata summary. 
Diagnosis Description Number of Images 
1 Benign or non-malignant disease 31 
2 Malignant, primary lung cancer 17 
3 Malignant metastatic 48 
All 154 JSRT nodule CXR images were used in our experiments despite around 30% 
of the nodules in these images being classified by the JSRT as either “Very subtle” or 
“Extremely subtle”. Human radiologist sensitivity scores were relatively low for these 
images as 69.4% and 60.4%, respectively as reported by the JSRT source paper. The JSRT 
categorizes images as follows in Table 5. 
Table 5. JSRT patient level diagnosis metadata summary. 
Diagnosis Description Number of Images 
Benign Benign lung nodule 54 
Malignant Malignant lung nodule 100 
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For testing, the LIDC-IDRI and JSRT datasets were also combined by aligning 
diagnosis labels and assigning JSRT benign images to a diagnosis label of “1” and 
malignant images to a diagnosis label of “2”. 
The models for each training epoch up to 25 epochs were used to extract pathological 
feature scores for the LIDC-IDRI, JSRT and combined image sets by inferencing. This 
resulted in a total of 250 fitted decision trees per experiment. A seven-column csv template 
was prepared containing columns for the Patient ID, placeholders for the five features of 
interest (including the “No Finding” class), and the diagnosis score 1 to 3 as determined 
by four experienced thoracic radiologists [69]. LIDC-IDRI diagnosis scores 2 and 3 were 
combined into a single malignancy class with 65 images representing malignant diagnosis 
and thereby allowing for a binary separation. Values for “Atelectasis”, “Effusion”, 
“Mass”, “No Finding” and “Nodule” were inferenced from the deep learning models as 
a score tuple and written to the placeholder columns to complete a data-frame of patients, 
inferenced feature scores and diagnosis labels. 
The data-frame was then randomly split into an 80:20 training/testing set, before 
being used to fit a decision tree classifier with a limited maximum depth of 3 (to avoid 
overfitting due to the small sample size), fitting on an entropy criterion. The fit accuracy 
was captured and written to a CSV file, with the decision tree visualization captured as 
an image file for any model with greater than 60% accuracy for further investigation of 
the associated confusion matrix and tree as a potentially useful multivariate diagnostic 
and malignancy stratification model. 
4. Results 
The experiment generated many fitted decision trees meeting the stated accuracy 
objective of 60%. The process was especially effective for the combined LIDC-IDRI and 
JSRT datasets, which yielded 633 such trees from a total of 750 candidate trees, 
representing an 84.4% success rate. This is impressive considering that candidate trees 
were fitted for all epochs, including undertrained early epochs where poor fit results were 
concentrated. 
Experiment C, based on ResNet-50 with triple attention network, proved to be the 
most consistent deep learning classifier, with 217 out of 250, or 86.8% success rate 
compared to 86.0%, and 80.4% for experiments A and B, respectively. This aligned well 
with our earlier deep learning holdout testing results presented in Figures 5–8, where 
experiment C provided the best overall results. All fitted decision trees, along with 
confusion matrices for each tree, have been made available as supplementary material. 
Recognizing that accuracy alone is of limited statistical value, especially for small and 
imbalanced datasets, we provide sensitivity, specificity, positive predictive value (PPV), 
false positive rate (FP Rate) and F1 value for each dataset as detailed in Tables 6–8 based 
on best fitted tree/s for each experiment as determined by interrogation of the confusion 
matrices for the fitted decision trees. 
Table 6. Summary of automatically generated decision tree metrics for LIDC-IDRI images. 
Test ID Accuracy (%) Sensitivity (%) Specificity (%) PPV (%) FP Rate (%) F1 
A 0.850 0.867 0.800 0.929 0.200 0.897 
B 0.850 0.933 0.600 0.875 0.400 0.903 
C 0.750 0.733 0.800 0.917 0.200 0.8148 
Table 7. Summary of automatically generated decision tree metrics for JSRT images. 
Test ID Accuracy (%) Sensitivity (%) Specificity (%) PPV (%) FP Rate (%) F1 
A 0.677 0.938 0.400 0.625 0.600 0.750 
B 0.677 0.875 0.467 0.636 0.533 0.737 
C 0.710 1.000 0.400 0.640 0.600 0.781 
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Table 8. Summary of automatically generated decision tree metrics for combined LIDC-IDRI and 
JSRT images. 
Test ID Accuracy (%) Sensitivity (%) Specificity (%) PPV (%) FP Rate (%) F1 
A 0.820 0.100 0.400 0.796 0.600 0.886 
B 0.760 0.800 0.667 0.849 0.333 0.824 
C 0.820 0.857 0.733 0.882 0.267 0.870 
4.1. Model Analysis-Individual Datasets 
The most accurate decision tree achieved 85.0% accuracy with sensitivity of 86.7%, 
specificity of 80.0%, positive predictive value of 92.9% with one false positive. This result 
was achieved for experiment from experiment A, using the LIDR-IDRI dataset. The 
confusion matrix for this result is shown in Figure 9a. 
  
(a) LIDC-IDRI Images (b) JSRT Images 
Figure 9. Confusion matrices for best results from LIDC-IDRI and JSRT inferencing datasets 
analysed individually. 
Inspection of this confusion matrix shows that this result, whilst promising, is based 
on a holdout test set of 20 images, being the 20% test split of the LIDC-IDRI dataset of size 
96. Nevertheless, the decision tree fitting this result, as shown in Figure 10, seems reasonable. 
 
Figure 10. Decision tree fitting best result from LIDC-IDRI Images. 
Notably, a high score for the “No Finding” feature results in a branch that indicates 
a benign condition unless a high score for “Effusion” is present, whilst a lower score for 
the “No Finding” feature, along with a high score for the “Mass” feature results in a 
malignancy classification. 
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The JSRT based experiments resulted in lower decision tree fit metrics than the LIDC-
IDRI tests. This is the expected result of our inclusion of subtle and very subtle nodule 
sample images. When reduced from a native image size of 2048 × 2048 pixels to the 
classifier default or 224 × 224 for DenseNet and 299 × 299 for the ResNet based classifiers, 
it is unlikely that these subtle nodules ranging from 1 mm to 15 mm diameter would still 
be visible as a detectable feature on the image. Nevertheless, we did achieve interesting 
results for this dataset with an overall best result from experiment C, which achieved 71% 
accuracy with good sensitivity of 100.0%, offset by limited specificity of 40%, positive 
predictive value of 64%, and a high false positive rate of 60%. The confusion matrix for 
this result is shown in Figure 9b. 
Again, this result is based on a relatively small test set, being 31 holdout samples 
from the JSRT test set. The decision tree fitting for this result is shown in Figure 11. 
 
Figure 11. Decision tree fitting best result from JSRT Images. 
The JSRT based model offers some interesting insights. Notably, the decision tree is 
rooted in “Effusion”, with high values for this feature associated with malignancy. Very 
low values for the “No Finding” feature in the presence of “Effusion” also lead to a 
malignancy classification. Once again, a high value for the “Mass” feature also leads to a 
malignancy classification. 
4.2. Model Analysis-Combined Dataset 
The best models from the individual LIDC-IDRI and JSRT datasets are promising but 
based on holdout test dataset of very limited size. To obtain the most statistically reliable 
results, we proceeded to fit decision trees against the combined LIDC-IDRI and JSRT 
datasets with aligned diagnosis labels. 
The confusion matrices for the highest accuracy results of each experiment for the 
combined LIDC-IDRI and JSRT datasets is shown in Figure 12a–c, with associated metrics 
in Table 8. The best result for combined dataset testing was achieved by experiment C, 
using a DenseNet classifier enhanced with a triple attention mechanism. Experiment C 
represents the best balance between accuracy, sensitivity, and specificity with scores of 
82%, 86% and 73%, respectively, resulting in a correct classification of 41 of the 50 test 
samples, with only 4 false positives (26.7%). Experiment B also performed relatively well, 
correctly classifying 38 of the 50 test samples with well-balanced accuracy, sensitivity, and 
specificity metrics of 76%, 80% and 67%, respectively, with 5 false positives (33.3%). 
Experiment A achieved a high accuracy of 82% by means of over-classification to the 
malignant class at the expense of specificity for the benign class, resulting in a high false 
positive rate of 60%. 






(a) Confusion Matrix Test A (b) Confusion Matrix Test B (c) Confusion Matrix Test C 
Figure 12. Confusion matrices for experiments A, B, and C using combined LIDC-IDRI and JSRT datasets. 
Note that in the medical context, false positives are preferable to false negatives, since 
follow-up radiology, such as CT scans and biopsy analysis, will achieve a more accurate 
diagnosis [69–71] and eliminate the false positive. On the other hand, a false negative 
result can lead to a missed diagnosis and inaction, which is particularly problematic in the 
case of lung cancer, where early detection has been shown to significantly improve 
outcomes [72]. The best model from experiment C achieved an accuracy of 82%, with a 
sensitivity of 86% and specificity of range 73%, which (allowing for sensitivity/specificity 
trade-off) is consistent with studies showing human radiologist performance in detecting 
symptomatic lung cancer from CXR to have a sensitivity of 54–84% and specificity of up 
to 90% [70]. 
The proposed experimental method is novel, and there are no directly comparable 
studies against which we can compare these results. Studies presenting deep learning 
classifiers for the ChestX-Ray14, and other CXR datasets do not typically test the 
generalization characteristics of the presented models against independent datasets. 
Where studies such as [6] do assess cross-database performance, this is done by fine-
tuning the model against the second datasets, thereby eliminating the independence of 
the second dataset and preventing use as a generalization study. We purposefully did not 
fine-tune our DenseNet-121 deep learning model against the LIDC-IDRI or JSRT datasets, 
preferring to preserve independence between the learning and inferencing datasets to 
promote unbiased cross-dataset feature extraction and realistic decision tree fitting. 
4.3. Combined Dataset Decision Tree Interpretation 
Example decision trees corresponding to the combined dataset results are shown in 
Figure 13a–c. These decision tree models explain the scores achieved by each test using a 
decision path and serve to illustrate the result of the end-to-end technique presented in 
this paper. Due to the small sample size of the combined LIDC-IDRI and JSRT datasets 
used for inference, it is not possible to claim that these decision tree models are clinically 
viable. However, even on this modest dataset, the results achieved are reasonable and 
could be expected to be greatly improved by additional inferencing samples. For example, 
all three decision trees are rooted at either the “Nodule” or “Mass” feature as expected, 
since these are the primary features for lung cancer. 
The model for experiment A shown as Figure 13a indicates that a high score for 
“Nodule” with the presence of Effusion is associated with malignancy classifications. 
Conversely, a high score for the “No Finding” feature results in a benign classification. 
The decision tree generated for experiment B, in Figure 13b, shows a high score for 
“Mass”, which leads to a malignancy classification, whilst a high score for “No Finding” 
leads to a benign classification. 




(a) Decision tree for experiment A 
 
(b) Decision tree for experiment B 
 
(c) Decision tree for experiment C 
Figure 13. Best fit trees for combined LIDC-IDR and JSRT inferencing datasets for experiments A, B, C and D. 
Experiment C yielded the best decision tree fitting results, as evident from Table 8. 
Therefore, we expected the decision tree for experiment C, as shown in Figure 13c, to 
provide the clearest insights into the relationship between our selected pathological 
features and lung cancer malignancy. This model shows that a high score for “Mass” 
combined with a low score for “No Finding” with “Effusion” leads to malignancy 
classification nodes. Low scores for “No Finding” with Nodule scores greater than 0.01 
also lead to malignant classifications. A low score for “No Finding”, along with a high 
score for “Atelectasis” leads to a benign classification, reflecting the weak relationship 
between this feature and lung cancer, as found in our literature review. We intend to 
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further refine these models using clinical studies and may filter out this feature in future 
iterations. 
Interestingly, both experiments A and C associate “Effusion” with malignancy, with 
the decision tree for experiment A separating 73% of samples on this feature. This could 
indicate that the models based on the combined dataset were sensitive enough to 
automatically detect the build-up of fluid and cancer cells between the chest wall and 
lungs, associated with malignant lung cancer known as Malignant Pleural Effusion [73]. 
In general, we found the higher levels of the generated decision trees correspond to 
our understanding of the lung cancer condition, with the lower levels of the tree being 
less consistent and sometimes counter-intuitive, especially for decision tree nodes 
containing only a small number of samples. 
5. Discussion 
Using a novel hybrid of deep learning multiple feature extraction and decision tree 
fitting, we have automatically mined lung cancer diagnostic models that are capable of 
stratifying lung cancer patient CXR images from an independent dataset into 
benign/malignant categories. Our best model using a combined LIDC-IDRI and JSRT 
dataset achieved sensitivity and specificity of 85.7% and 73.3%, respectively, with a 
positive predictive value of 88.2%. Our best model using the LIDC-IDRI dataset alone 
achieved sensitivity and specificity of 86.7% and 80.0%, respectively, with a positive 
predictive value of 92.9%, using a smaller holdout test set which leads us to favour the 
lower but more statistically significant combined dataset result. These results are 
interpretable using human readable decision tree diagrams. The decision tree models 
provide explanations into lung cancer malignancy that may lead clinicians to consider 
factors that would otherwise be missed in a high-pressure environment, where, on 
average, radiologists may be required to interpret an image every 3–4 s in a workday [74]. 
We consider this multi-variate approach to be more useful than a narrow automated 
second reading for nodules only, since it aims to enhance the qualitative reasoning process 
undertaken by trained physicians, potentially increasing efficiency and reducing errors 
[8]. It is possible to conceive an implementation of our system as an augmented reality 
application presenting an interpreted overlay to radiologists, perhaps adapting to the 
clinician’s eye movements to ensure that attention is given to parts of the CXR that are 
important but have not yet captured the clinician’s attention. 
The results presented in this research show the potential of hybrid machine learning 
computer vision techniques in automatically mining explainable, multivariate diagnostic 
scoring models from CXR image data. Whilst none of the developed models could be 
considered fit for clinical purposes at this stage, our malignancy classification results and 
good matching of decision tree structure to the medical literature, suggests that the 
technique we have developed is able to capture important pathological information and 
is worthy of further refinement and clinical trialling. Our technique provides an end-to-
end process, resulting in clearly explainable insights that are amenable to expert oversight, 
thereby paving the way for clinical adoption. 
6. Conclusions 
Around 90% of missed lung cancer detections from radiological investigation stem 
from the CXR imaging mode [75]. Interpretable computer vision would provide a useful 
strategy to reduce radiologists’ observed error by broadening clinical attention to multiple 
abnormalities. Such tooling would also help to minimize missed diagnosis, resulting from 
early satisfaction of search [76], where obvious anomalies capture attention at the expense 
of more subtle abnormalities. 
Given the small size of the LIDC-IDRI and JSRT datasets used for the experiments 
diagnostic ground truth, our results suggest that with additional data and further 
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refinement of this method could be used to develop useful clinical methods to assist in the 
diagnosis and malignancy stratification of lung cancer. 
Our future directions include utilizing state-of-the-art signal-to-noise improvement 
techniques applied to the CXR pre-processing pipeline, customization of the deep 
learning feature extraction algorithm to include wavelet filtering, followed by reference 
implementation in a federated deep learning framework to reduce patient selection bias 
and guarantee data privacy, thereby providing a path to clinical validation. 
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